Glycosylation analysis can provide a deep and nuanced understanding of immune cell phenotype and function.

Capturing the Nuances of Immune Cells Using Glycobiology

Adventitious agent testing is transitioning toward testing methods that use next-generation sequencing.

Examining Next-Gen Technology for Adventitious Agent Testing

Image analysis algorithms coupled with microscopy techniques can be used to characterize aggregates of therapeutic proteins.

Image Analysis Algorithm for Therapeutic mAb Aggregate Analysis

Topic

Webcasts

Webinar Date/Time: Tuesday, December 12, 2023

Session 1: 9:00 am EDT | 1:00pm GMT | 2:00pm CET
Session 2: 1:00 pm EDT| 12:00pm CDT| 10:00am PDT

Economic Modeling of Multi-Column Chromatography

Webinar Date/Time: Mon, Dec 4, 2023 11:00 AM EST

Nature vs. nurture:  Rapidly assess the impact of cell culture conditions on mAb quality and production

Webinar Date/Time: Tue, Dec 5, 2023 11:00 AM EST

Droplet Size Analysis of Pharmaceutical Emulsions: Lab and In-Process Solutions

Webinar Date/Time: Thu, Dec 14, 2023 11:00 AM EST

Automating Cell-Based Assays and Reducing Variability and Time to Results

Feliza Mirasol is the science editor for 

Articles

Matthew Lauber, senior director—Cell and Gene Therapy, Consumables & Lab Automation, at Waters Corporation highlights the company’s motivation behind their new bioanalysis kit for oligonucleotides.

The Need for New Bioanalysis Technology (AAPS PharmSci 360)

Matthew Lauber, senior director—Cell and Gene Therapy, Consumables & Lab Automation, at Waters Corporation discusses the analytical and downstream purification challenges of oligonucleotides.

Discussing Oligonucleotide Challenges in Analytics and Purification (AAPS PharmSci 360)

Dujuan Lu, PhD, global leader—E&L, SGS Health Sciences, talks about the differences in designing E&L testing for combination products vs. conventional pharmaceuticals.

Distinguishing E&L Testing for Combination Products (AAPS PharmSci 360)

Dujuan Lu, PhD, global leader—E&L, SGS Health Sciences, discusses the differences in how E&L study design should be approached based on whether the study  is following ISO or USP standards. 

Discussing E&L Study Design Between ISO and USP (AAPS PharmSci 360) 

Hollie Barton, senior director, Chromatographic Services, for the PPD clinical research business of Thermo Fisher Scientific, highlights one approach to ensuring the continuation of analytical expertise.

Ensuring the Next Generation of Analytical Experts (AAPS PharmSci 360)

Hollie Barton, senior director, Chromatographic Services, for the PPD clinical research business of Thermo Fisher Scientific, discusses ways that labs are addressing the pressure of rapid analytical turnaround times.

Biopharmaceutical Analysis

Capturing the Nuances of Immune Cells Using Glycobiology

Examining Next-Gen Technology for Adventitious Agent Testing

Image Analysis Algorithm for Therapeutic mAb Aggregate Analysis